Thrombophilia Screening After Severe IUGR

Central Hospital, Nancy, France

Status: Enrolling

Conditions: Pregnancy Complications; Thrombophilia; IUGR

Treatments: Biological: thrombophilia screening

Study type: Observational

Funder types: Other

Identifiers

NCT05551078

2022PI102

Details and patient eligibility

About

This retrospective study aims to assess the input of thrombophilia screening in pregnant women with severe intra-uterine growth restricted babies.

Enrollment: 100 estimated patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Women over 18 years old
• Pregnant women
• IUGR defined by an EFW <3rd centile
• IUGR before 25 GW

Exclusion criteria

• none

Trial design

100 participants in 1 patient group

pregnant women with severe IUGR

Treatment:

Biological: thrombophilia screening